Dr. Matthew James Baker, MD

Dr. Baker practices at Collier Neurologic Specialists in Naples, Florida.

Dr. Baker's NPI, 1154372167, was assigned on May 15, 2006. Dr. Baker graduated from USF Health Morsani College of Medicine in 1997. Dr. Baker holds Florida license ME81973.

Dr. Baker's primary practice is Collier Neurologic Specialists, at 3200 Bailey Ln Ste 200 Suite 200, Naples, FL 34105. The practice phone is (239) 262-8971.

Dr. Baker's primary practice is Collier Neurologic Specialists in Naples, Florida. Dr. Baker is also affiliated with NCH Baker Hospital. The medical group on file is Collier Neurologic Specialists. Dmand AI also links Dr. Baker to 4 more hospitals, 2 home health agencies, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baker practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Baker's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Baker is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Baker is licensed in Florida.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Baker treats.

CMS data shows 27,122 Medicare services from Dr. Baker across 12 procedure codes in 2024, for 609 Medicare patients. Medicare paid $1,369,990 for them.

CMS counts 609 Medicare patients who saw Dr. Baker in 2024. The largest group is 75 to 84, with 242 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baker's median patient age at 68, with 69% women.

In 2024, Dr. Baker wrote 4,710 Medicare Part D claims for 502 patients. 80% of them were for generic drugs. CMS names the drug for 4,203 of them, across 102 drugs with 11 or more claims each, at $3,410,472 in total drug cost. In 2023, CMS named 4,327 claims across 104 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Baker for performance year 2024, reported as part of a group. Dr. Baker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baker as offering telehealth. CMS counts 30 procedures of skin biopsy by Dr. Baker, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Baker, published from 2006 to 2021. Dr. Baker's most frequent co-authors are Steven Brem, MD, Tiffany Wingchoy Chow, MD and Surasak Phuphanich, MD.

Dmand AI links Dr. Baker to 1 clinical trial. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis. Open Payments lists research payments to Dr. Baker that name 1 trial.

CMS Open Payments shows 3,700 general payments to Dr. Baker from 75 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Biogen, Inc. paid the most, $517,828. It also lists 23 research payments totaling $11,125 from 2017 to 2023, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Baker, most recently CMS Stage 1 EHR in 2013.

Dr. Baker graduated from USF Health Morsani College of Medicine in 1997.

Dr. Baker is in network with 16 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.